News | August 12, 2022
Aurobindo Pharma posts consolidated Q1FY23 PAT of Rs. 520.54 Cr
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 1508.55 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 264.09 crores during the period ended June 30, 2022.
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
The company has reported total income of Rs. 21.73 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 1463.03 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.
he company has reported total income of Rs. 5478.62 crores during the period ended June 30, 2022.
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Subscribe To Our Newsletter & Stay Updated
